52 Results for "

Apelin

" in MedChemExpress (MCE) Product Catalog:
Products (52)

52 Results for "Apelin" in MCE Product Catalog:

10
10 Publications Verification
Cat. No.: HY-P1944
CAS No.: 217082-58-1
Apelin-13 is an endogenous ligand for the G-protein coupled receptor angiotensin II protein J (APJ), activating this G protein-coupled receptor with an EC 50 value of 0.37 nM. Apelin-13 is widely distributed in the central and peripheral nervous systems. Apelin-13 has vasodilatory and antihypertensive effects. Apelin-13 also can be used for researching type 2 diabetes and metabolic syndrome .
loading...
    loading...
10
10 Publications Verification
Cat. No.: HY-P1944A
Apelin-13 TFA is an endogenous ligand for the G-protein coupled receptor angiotensin II protein J (APJ), activating this G protein-coupled receptor with an EC 50 value of 0.37 nM. Apelin-13 TFA has vasodilatory and antihypertensive effects. Apelin-13 TFA also can be used for researching type 2 diabetes and metabolic syndrome .
loading...
    loading...
10
10 Publications Verification
Cat. No.: HY-103254
CAS No.: 877636-42-5
Purity:  99.55%
Research Areas:  

Neurological Disease

ML221 is a potent apelin (APJ) functional antagonist, inhibiting apelin-13-mediated activation of APJ, with IC50s of 0.70 μM in the cAMP assay, and 1.75 μM in the β-arrestin assay, and EC80 of 10 nM in both assays.
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-P2106
CAS No.: 1886973-05-2
Research Areas:  

Cardiovascular Disease

Elabela(19-32) is an active fragment of ELABELA (ELA) that binds to apelin receptor (APJ). Elabela(19-32) activates the Gαi1 and β-arrestin-2 signaling pathways with EC50s of 8.6 nM and 166 nM. Elabela(19-32) induces receptor internalization and reduces arterial pressure, exerts positive inotropic effects on the heart .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-P2106A
Research Areas:  

Cardiovascular Disease

Elabela(19-32) TFA is an active fragment of ELABELA (ELA) that binds to apelin receptor (APJ). Elabela(19-32) TFA activates the Gαi1 and β-arrestin-2 signaling pathways with EC50s of 8.6 nM and 166 nM. Elabela(19-32) TFA induces receptor internalization and reduces arterial pressure, exerts positive inotropic effects on the heart .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-P1033
CAS No.: 217082-60-5
Synonyms: [pGlu1]-Apelin-13
Target:  

Apelin Receptor (APJ)

Research Areas:  

Cardiovascular Disease

[Pyr1]-Apelin-13 is a highly potent, selective endogenous apelin receptor (APJ) agonist.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-122197
CAS No.: 2579689-83-9
Purity:  99.88%
Research Areas:  

Cancer

ML339 is a selective CXCR6 antagonist with an IC50 of 140 nM. ML339 antagonizes β-arrestin recruitment and cAMP signaling pathway of human CXCR6 receptor induced by CXCL16, with IC50 of 0.3 μM and 1.4 μM, respectively. ML339 shows weaker activity against the recruitment of β-arrestin in mouse CXCR6 receptors, with an IC50 of 18 μM. ML339 has no inhibitory effect on CXCR5CXCR4CXCR6 and apelin receptor (APJ), with IC50 >79 μM. ML339 has the potential to promote the development of prostate cancer research .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P2537
CAS No.: 229961-08-4
Research Areas:  

Others

Apelin-12 is one of the most potent C-terminal fragments of the polypeptide that possesses a high affinity to orphan receptor APJ receptor. Apelin-12 is involved in the regulation of body fluid homeostasis and in the central control of feeding. Apelin-12 blocks HIV-1 entry through APJ receptor. Apelin-12 exerts neuroprotective effect .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P2196A
Target:  

Apelin Receptor (APJ)

Research Areas:  

Cancer

ELA-32(human) TFA is a potent, high affinity apelin receptor agonist (IC50=0.27 nM; Kd=0.51 nM). ELA-32(human) TFA exhibits no binding GPR15 and GPR25. ELA-32(human) TFA activates the PI3K/AKT pathway and promotes self-renewal of hESCs via cell-cycle progression and protein translation. ELA-32(human) TFA also potentiates the TGFβ pathway, priming hESCs toward the endoderm lineage. ELA-32(human) TFA stimulates angiogenesis in HUVEC cells.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P77874
Purity:  ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: Apelin; APJ endogenous ligand; APEL
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-109111
CAS No.: 2049980-18-7
Purity:  99.94%
Synonyms: AMG 986
Target:  

Apelin Receptor (APJ)

Research Areas:  

Others

Azelaprag (Example 263.0) is a candidate active molecule for an Apelin receptor agonist with an EC50 of 0.32 nM for the apelin receptor .
loading...
    loading...
Cat. No.: HY-139485
CAS No.: 2055200-88-7
Purity:  99.33%
Target:  

Apelin Receptor (APJ)

Research Areas:  

Cardiovascular Disease

BMS-986224 is a potent, selective and orally active APJ receptor agonist (Kd = 0.3 nM). BMS-986224 exhibits similar receptor binding and signaling profile to (Pyr 1) apelin-13. BMS-986224 has the potential for the research of heart failure .
loading...
    loading...
Cat. No.: HY-103080
CAS No.: 1586787-08-7
Purity:  99.89%
Target:  

Apelin Receptor (APJ)

Research Areas:  

Cardiovascular Disease

CMF019 is an orally active, potent and small molecule agonist at Apelin receptor (APJ) with G protein bias. CMF019 binds to APJ with pKi values of 8.58, 8.49 and 8.71 for human, rat, and mouse, respectively. CMF019 mimics the beneficial cardiovascular actions of apelin in rodents . Apelin receptor (APJ) is a G protein-coupled receptor (GPCR) activated by the endogenous peptide apelin. CMF019 is promising for research of chronic diseases, such as, pulmonary arterial hypertension .
loading...
    loading...
Cat. No.: HY-108003
CAS No.: 1876450-21-3
Purity:  99.95%
Target:  

Apelin Receptor (APJ)

Research Areas:  

Cardiovascular Disease

MM 07 is a biased apelin receptor agonist, with a KD of 300 nM in CHO-K1 cells and a KD of 172 nM in human heart.
loading...
    loading...
Cat. No.: HY-125976
CAS No.: 2080311-92-6
Purity:  99.8%
Target:  

Apelin Receptor (APJ)

Research Areas:  

Cardiovascular Disease

ML233 is a non-peptide based potent apelin receptor (APJ) agonist (EC50=3.7 μM). ML233 displays >21-fold selective over the closely related angiotensin 1 (AT1) receptor (>79 μM) .
loading...
    loading...
Cat. No.: HY-P1066
CAS No.: 217082-57-0
Research Areas:  

Infection

Apelin-17(human, bovine) is an endogenous orphan G protein-coupled receptor APJ agonist. Apelin-17(human, bovine) binds to human APJ receptors expressed in HEK 293 cells (pIC50=9.02). Apelin-17(human, bovine) inhibits the entry of some HIV-1 and HIV-2 into the NP2/CD4 cells expressing APJ .
loading...
    loading...
Cat. No.: HY-P2271
CAS No.: 1313027-43-8
Target:  

Apelin Receptor (APJ)

Research Areas:  

Cancer

MM 54 (compound 5) is a competitive antagonist at APJ, with an IC50 of 93 nM. MM 54 behaves as a potent and selective inhibitor of apelin binding and APLNR activation .
loading...
    loading...
Cat. No.: HY-P1064
CAS No.: 252642-12-9
Apelin-36(human) is an endogenous orphan G protein-coupled receptor APJ agonist, with an EC50 of 20 nM. Apelin-36(human) shows high affinity to human APJ receptors expressed in HEK 293 cells (pIC50=8.61). Apelin-36 has been linked to two major types of biological activities: cardiovascular and metabolic. Apelin-36(human) inhibits the entry of some HIV-1 and HIV-2 into the NP2/CD4 cells expressing APJ .
loading...
    loading...
Cat. No.: HY-P2197
CAS No.: 1784687-32-6
Research Areas:  

Inflammation/Immunology

ELA-11(human), a peptide, is a full agonist of human apelin receptor, with a pKi of 7.85. ELA-11(human) completely inhibits Forskolin-induced cAMP production and stimulates β-arrestin recruitment .
loading...
    loading...
Cat. No.: HY-P3162A
Target:  

Apelin Receptor (APJ)

Research Areas:  

Cardiovascular Disease

(Ala13)-Apelin-13 TFA is a potent apelin receptors (APJ) antagonist. (Ala13)-Apelin-13 TFA inhibits gastric motility through vagal cholinergic pathway .
loading...
    loading...